|
PIK3C2A expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.055000E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.768800E-01 |
| Normal-vs-AfricanAmerican |
7.841600E-01 |
| Normal-vs-Asian |
8.751200E-01 |
| Caucasian-vs-AfricanAmerican |
2.745400E-01 |
| Caucasian-vs-Asian |
6.528000E-01 |
| AfricanAmerican-vs-Asian |
9.322200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.302600E-01 |
| Normal-vs-Female |
5.919000E-01 |
| Male-vs-Female |
9.205200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.006200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.916400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.272400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.030400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.713760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.218200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.575590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.745200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.348200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.625930E-02 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
5.836800E-01 |
| Normal-vs-Pheochromocytoma |
6.473600E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.371200E-01 |
| Paraganglioma-vs-Pheochromocytoma |
8.046000E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
3.414600E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.118000E-01 |
|
|
